Norflex

   
Google
 
Web NewDrugInformation.com

Norflex


Drug - Norflex
The trade name of the product as shown on the labeling.

Dosage - TABLET, EXTENDED RELEASE; ORAL
The product dosage form and route separated by a semi-colon.

Active Ingredient(s) - Orphenadrine Citrate
Multiple ingredients are in alphabetical order.

Strength - 100MG
The potency of the active ingredient(s), Orphenadrine Citrate. May repeat for multiple part products.

Applicant - 3M
The firm name holding legal responsibility for Norflex. The firm name is condensed to a maximum twenty character unique string.

New Drug Application (NDA) Number - 012157
The FDA assigned number to Norflex. Format is nnnnnn.

Product Number - 001
The FDA assigned number to identify Norflex. Each strength is a separate product. May repeat for multiple part products. Format is nnn.

Therapeutic Equivalence (TE) Code -
The TE Code indicates the therapeutic equivalence rating of generic to innovator Rx products.

Approval Date - Approved Prior to Jan 1, 1982
The date Norflex was approved as stated in the FDA approval letter to the applicant. The format is Mmm dd, yyyy. Products approved prior to the January 1, 1982 contain the phrase: "Approved prior to Jan 1, 1982".

Reference Listed Drug (RLD) - No
The pioneer or innovator of Norflex. The RLD identifies the product Abbreviated New Drug Applications (ANDA) use as a reference. Format is Yes or No.

Type - DISCN
The group or category of approved drugs Norflex is in. Format is RX, OTC, DISCN.

Applicant Full Name - 3m Pharmaceuticals Inc
The full name of the firm holding legal responsibility for the new application of Norflex.

Norflex